Noded.

In addition to the predefined 3-bone met limit, this post-defined secondary analysis of the STAMPEDE trial adds men with non-regional lymph nodes as only site of metastatic disease (n=181) to the list of those who achieve an overall survival advantage with the addition of prostate radiation. | Ali, JAMA Oncol 2021